This compound is a pharmaceutical intermediate primarily used as a reference standard for the impurity profiling of ticagrelor. It features a complex polycyclic structure containing multiple ring systems, including aromatic heterocycles and ether groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
pharmaceutical intermediate
Afatinib Impurity J
pharmaceutical intermediate
3-[(3R,4S)-3,4-Dimethylpiperidin-4-yl]phenol
pharmaceutical intermediate
Tert-Butyl ((5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)(2,2,2-trifluoroethyl)carbamate
pharmaceutical intermediate
3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one;4-nitrobenzoic acid
pharmaceutical intermediate
3-[(3aR,4S,6R,6aS)-4-(2-hydroxyethoxy)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]-5-propylsulfanyl-6H-triazolo[4,5-d]pyrimidin-7-one
CQHLYYLTSYUATH-RSLMWUCJSA-N
CCCSC1=NC2=C(C(=O)N1)N=NN2[C@@H]3C[C@@H]([C@@H]4[C@H]3OC(O4)(C)C)OCCO
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.